Cullen Frost Bankers Increases Intuitive Surgical Position to 82,056 Shares Valued at $36.7M
Cullen Frost Bankers Inc. boosted its stake in Intuitive Surgical by 4.4% in Q3, acquiring 3,450 shares to total 82,056 shares valued at $36.7M. Institutional investors and hedge funds now hold 83.64% of Intuitive Surgical’s outstanding shares after various Q3 position increases.
1. Cullen Frost Bankers Increases Stake in Intuitive Surgical
During the third quarter, Cullen Frost Bankers Inc. expanded its position in Intuitive Surgical by 4.4%, acquiring an additional 3,450 shares and bringing its total holdings to 82,056 shares. According to the firm’s latest SEC filing, those shares represented a position valued at approximately $36.7 million as of the end of the quarter, underscoring the bank’s confidence in the surgical robotics leader’s long-term growth prospects.
2. Broader Institutional Activity Reflects Continued Confidence
Other asset managers also adjusted their Intuitive Surgical allocations in the same period. Commerzbank Aktiengesellschaft FI added 752 shares, lifting its total to 11,802 shares worth $5.3 million, while Whittier Trust Co. of Nevada boosted its stake by 8.8%—an additional 3,964 shares—for a total of 49,093 shares valued at $22.2 million. Meanwhile, Whittier Trust Co. increased its position by 7.7% to 100,093 shares ($45.3 million), CIBC Asset Management added 2,061 shares for a 1.3% rise to 159,566 shares ($71.4 million), and Robocap Asset Management grew by 27.2% to 14,542 shares ($6.5 million). These moves helped push the institutional ownership level to over 83% of shares outstanding.
3. Analyst Upgrades and Earnings Beat Highlight Growth Outlook
A series of recent research notes have raised price targets and reaffirmed buy ratings for Intuitive Surgical, with Truist Financial lifting its target to $650 and Royal Bank of Canada matching that level. In its Q4 financial report, Intuitive Surgical delivered $2.53 in earnings per share—26 cents above consensus—driving quarterly revenue of $2.87 billion, an 18.8% year-over-year increase. The company’s net margin expanded to 28.4%, while return on equity stood at 15.2%, supporting analyst forecasts for full-year EPS of approximately $6.43 and reinforcing the stock’s moderate-buy consensus.
4. Insider Sales Signal Caution on Short-Term Valuation
Insider transactions during the quarter included Senior Vice President Mark Brosius’s sale of 464 shares at an average price of $548.49, reducing his personal stake by nearly 78%, and Director Craig H. Barratt’s disposition of 750 shares at an average of $580.00. Collectively, insiders sold 55,714 shares valued at $31.6 million, bringing insider ownership down to 0.70% of the total float and suggesting some executives are taking profits despite strong operating trends.